Mediphage is a biotech company developing non-viral safe and redosable gene therapies. ministring DNA (msDNA), which is Mediphage’s flagship technology, is a versatile linear covalently closed (LCC) DNA construct that can accommodate large transgenes (> 4.7 kb) and address various applications. The company is evaluating the therapeutic potential of its non-viral platform technology in a number of indications internally and through external collaborations.